NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 08 04:00PM ET
6.46
Dollar change
-0.13
Percentage change
-1.97
%
IndexRUT P/E- EPS (ttm)-1.91 Insider Own3.53% Shs Outstand75.10M Perf Week-1.97%
Market Cap488.06M Forward P/E- EPS next Y-1.66 Insider Trans-2.45% Shs Float72.71M Perf Month32.11%
Income-108.68M PEG- EPS next Q-0.37 Inst Own54.30% Short Float14.66% Perf Quarter-27.98%
Sales0.00M P/S- EPS this Y0.47% Inst Trans-18.07% Short Ratio6.62 Perf Half Y6.60%
Book/sh3.21 P/B2.01 EPS next Y-8.45% ROA-50.94% Short Interest10.66M Perf Year-29.93%
Cash/sh3.62 P/C1.78 EPS next 5Y12.79% ROE-68.01% 52W Range4.70 - 10.44 Perf YTD-7.18%
Dividend Est.- P/FCF- EPS past 5Y12.11% ROI-41.28% 52W High-38.10% Beta2.90
Dividend TTM- Quick Ratio7.25 Sales past 5Y0.00% Gross Margin- 52W Low37.45% ATR (14)0.44
Dividend Ex-Date- Current Ratio7.25 EPS Y/Y TTM26.24% Oper. Margin- RSI (14)53.58 Volatility6.49% 7.20%
Employees74 Debt/Eq0.09 Sales Y/Y TTM- Profit Margin- Recom1.09 Target Price24.50
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q30.13% Payout- Rel Volume0.74 Prev Close6.59
Sales Surprise- EPS Surprise3.58% Sales Q/Q- EarningsMay 08 BMO Avg Volume1.61M Price6.46
SMA206.20% SMA504.47% SMA200-5.11% Trades Volume1,198,129 Change-1.97%
Date Action Analyst Rating Change Price Target Change
Jan-28-25Initiated Evercore ISI Outperform $23
Dec-20-24Initiated Chardan Capital Markets Buy $20
Oct-14-24Resumed Leerink Partners Outperform $20
Jul-24-24Initiated ROTH MKM Buy $36
May-29-24Initiated Robert W. Baird Outperform $27
Apr-15-24Initiated Leerink Partners Outperform $20
Dec-05-23Initiated Canaccord Genuity Buy $9
Dec-09-22Resumed ROTH Capital Buy $25
Nov-16-22Initiated RBC Capital Mkts Outperform $5
Aug-26-22Initiated Oppenheimer Outperform $3.50
May-08-25 07:00AM
May-07-25 12:33PM
Apr-24-25 07:00AM
Apr-23-25 07:42PM
Apr-21-25 04:01PM
10:33PM Loading…
Apr-20-25 10:33PM
Apr-15-25 07:00AM
Mar-24-25 04:01PM
Mar-22-25 10:30AM
Mar-21-25 11:50AM
Mar-17-25 07:00AM
Mar-14-25 11:40AM
Mar-06-25 07:00AM
Mar-04-25 07:00AM
Feb-28-25 11:30AM
07:00AM Loading…
Feb-20-25 07:00AM
Feb-13-25 04:14PM
Feb-12-25 01:25PM
Feb-04-25 07:00AM
Jan-31-25 07:20AM
Jan-30-25 07:00AM
Jan-20-25 10:48AM
Dec-19-24 07:00AM
Dec-16-24 07:00AM
Dec-11-24 07:00AM
Dec-05-24 07:00AM
Dec-03-24 07:00AM
Dec-02-24 07:00AM
Nov-18-24 07:00AM
Nov-13-24 07:00AM
04:01PM Loading…
Nov-07-24 04:01PM
Oct-24-24 07:00AM
Oct-12-24 06:05PM
Sep-09-24 04:01PM
Sep-04-24 07:00AM
Aug-13-24 07:00AM
Aug-12-24 09:02PM
Aug-09-24 08:44AM
06:00AM
Aug-06-24 04:01PM
07:00AM
Jul-29-24 07:00AM
Jul-17-24 07:00AM
Jul-06-24 07:21AM
Jul-04-24 02:13PM
Jun-28-24 07:00AM
Jun-21-24 07:00AM
Jun-20-24 07:00AM
Jun-18-24 12:31PM
Jun-14-24 09:40AM
Jun-05-24 11:42AM
May-29-24 09:40AM
May-28-24 07:00AM
May-23-24 03:41PM
May-18-24 09:32AM
May-10-24 11:00AM
May-09-24 04:01PM
08:00AM
06:49AM
May-08-24 09:00PM
04:01PM
May-04-24 08:00AM
May-02-24 07:00AM
Apr-25-24 07:00AM
Apr-08-24 06:59AM
Apr-02-24 07:00AM
Apr-01-24 05:00PM
Mar-19-24 08:00AM
Mar-11-24 07:00AM
Mar-10-24 11:10AM
Mar-08-24 10:46AM
07:00AM
Mar-07-24 07:13AM
06:00AM
Mar-01-24 09:00AM
Feb-28-24 07:05AM
Feb-22-24 07:00AM
Feb-07-24 07:00AM
Jan-24-24 09:00AM
Jan-08-24 12:27PM
07:45AM
Dec-17-23 05:49PM
Dec-14-23 07:30AM
Dec-11-23 12:19PM
Nov-02-23 04:01PM
Oct-30-23 12:11PM
Oct-26-23 07:30AM
Oct-24-23 07:30AM
Oct-03-23 07:30AM
Sep-14-23 07:30AM
Sep-12-23 07:30AM
Aug-28-23 07:30AM
Aug-14-23 07:30AM
Aug-03-23 04:01PM
07:30AM
Jul-31-23 08:30AM
Jun-22-23 08:42AM
08:30AM
Jun-21-23 12:08PM
Jun-20-23 08:30AM
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barrow RobertChief Executive OfficerMar 25 '25Sale6.7421,208142,942856,556Mar 26 05:00 PM
Karlin DanielChief Medical OfficerMar 25 '25Sale6.746,83646,075446,177Mar 26 05:00 PM
Sullivan MarkChief Legal OfficerMar 25 '25Sale6.746,57644,322316,621Mar 26 05:00 PM
Liao CarrieChief Accounting OfficerMar 25 '25Sale6.742,34715,819144,923Mar 26 05:00 PM
MARK SULLIVANOfficerMar 25 '25Proposed Sale6.746,57644,304Mar 25 04:11 PM
CARRIE LIAOOfficerMar 25 '25Proposed Sale6.742,34715,812Mar 25 04:09 PM
ROBERT B BARROWOfficerMar 25 '25Proposed Sale6.7421,208142,883Mar 25 04:06 PM
DANIEL ROLLINGS KARLINOfficerMar 25 '25Proposed Sale6.746,83646,056Mar 25 04:03 PM
Barrow RobertChief Executive OfficerDec 26 '24Sale7.4319,106141,958526,666Dec 27 04:31 PM
Liao CarrieChief Accounting OfficerDec 26 '24Sale7.432,27316,88897,270Dec 27 04:31 PM
Karlin DanChief Medical OfficerDec 26 '24Sale7.436,64349,357338,013Dec 27 04:30 PM
Sullivan MarkChief Legal OfficerDec 26 '24Sale7.434,51933,576173,197Dec 27 04:30 PM
ROBERT B BARROWOfficerDec 26 '24Proposed Sale7.4319,106141,979Dec 26 04:39 PM
MARK SULLIVANOfficerDec 26 '24Proposed Sale7.434,51933,581Dec 26 04:31 PM
DAN ROLLINGS KARLINOfficerDec 26 '24Proposed Sale7.436,64349,365Dec 26 04:30 PM
CARRIE LIAOOfficerDec 26 '24Proposed Sale7.432,27316,891Dec 26 04:28 PM
GRYSKA DAVID WDirectorDec 05 '24Buy7.172,50017,92519,851Dec 05 04:30 PM
Sullivan, MarkOfficerSep 25 '24Proposed Sale5.984,43026,487Sep 25 08:31 PM
Liao CarrieChief Accounting OfficerSep 25 '24Sale5.982,35214,06599,543Sep 25 08:30 PM
Barrow RobertChief Executive OfficerSep 25 '24Sale5.9819,771118,231545,772Sep 25 08:29 PM
Karlin, DanOfficerSep 25 '24Proposed Sale5.986,87141,081Sep 25 08:29 PM
Karlin DanChief Medical OfficerSep 25 '24Sale5.986,87141,089344,656Sep 25 08:29 PM
Sullivan MarkChief Legal OfficerSep 25 '24Sale5.984,43026,491177,716Sep 25 08:28 PM
Barrow, RobertOfficer, DirectorSep 25 '24Proposed Sale5.9819,771118,210Sep 25 08:27 PM
GRYSKA DAVID WDirectorAug 23 '24Buy5.983,50020,93017,351Aug 26 07:00 PM
Halperin Wernli MiriExecutive PresidentAug 21 '24Option Exercise3.7050,000185,000235,000Aug 22 04:30 PM
Barrow RobertChief Executive OfficerAug 19 '24Buy6.315003,155565,043Aug 20 09:14 PM
Barrow RobertChief Executive OfficerAug 20 '24Buy6.125003,060565,543Aug 20 09:14 PM
Karlin DanChief Medical OfficerJun 25 '24Sale7.226,92549,998351,527Jun 25 07:00 PM
Sullivan MarkChief Legal OfficerJun 25 '24Sale7.2217,854128,906182,146Jun 25 07:00 PM
Barrow RobertChief Executive OfficerJun 25 '24Sale7.2215,659113,058564,543Jun 25 07:00 PM